Relafen 750, or unique formulation of naproxen, offers an fascinating case from the biochemical pharmacy view. The process of action, primarily involving blocking of cyclooxygenase enzymes namely COX-1 and COX-2 – leads to significant decrease in prostaglandin creation. Within the biochemical framework, this drug's potency is closely related to t